|
- 2019
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life studyKeywords: airway obstruction reversibility, circulating eosinophils, FENO, omalizumab, severe allergic asthma Abstract: Omalizumab may modulate airway remodeling in severe asthma. Using forced expiratory volume in 1 second (FEV1) as a surrogate of airway remodeling, we aimed to investigate if an omalizumab add-on in severe allergic asthma may lead to a persistent reversal of airway obstruction and to evaluate the potential biomarkers of airway obstruction reversibility
|